APhA will announce it supports the Drug Quality and Security Act (H.R. 3204). While APhA does have some concerns with the proposed legislation, the Association believes it would protect the public from harm while maintaining access for consumers to important and often life-saving compounded preparations.
In the last year, APhA has communicated constantly with Members of Congress and their staff to help develop and craft compounding legislation. Now is a crucial moment in the legislative process.
H.R. 3204 recently passed the House by voice vote. The Senate is expected to take it up in the weeks ahead. The Association plans to send a letter of support to the Senate this week.
The Drug Quality and Security Act is the new bill that addresses both compounding and track and trace on which agreement was reached by leaders of the House Energy & Commerce Committee and Senate Health, Education, Labor, & Pensions Committee.